📈 Stocks
Novartis Shares Slump 13% on Failed Clinical Trial, Amgen Drops 9%
(just now)
Novartis shares plummeted 13% following a failed clinical trial for del-desiran, while Amgen shares dropped 9% on contagion fears, pressuring the Dow…